ATLAS / Macro Radar / Reporting / DSGN

Design Therapeutics, Inc. (DSGN) reporting calendar

Design Therapeutics, Inc. files periodic reports with the SEC as DSGN on Nasdaq. Atlas tracks 21 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
17 Jul 2026 – 26 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
28 Apr 2026
Reports on record
21

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202628 Apr 202628 days0001193125-26-187063
10-K31 Dec 20259 Mar 202668 days0001193125-26-098491
10-Q30 Sep 20255 Nov 202536 days0001193125-25-266970
10-Q30 Jun 20257 Aug 202538 days0000950170-25-105062
10-Q31 Mar 20257 May 202537 days0000950170-25-065643
10-K31 Dec 202410 Mar 202569 days0000950170-25-035910
10-Q30 Sep 20247 Nov 202438 days0000950170-24-123349
10-Q30 Jun 20245 Aug 202436 days0000950170-24-090337
10-Q31 Mar 20248 May 202438 days0000950170-24-055788
10-K31 Dec 202319 Mar 202479 days0000950170-24-033492
10-Q30 Sep 202313 Nov 202344 days0000950170-23-062958
10-Q30 Jun 202314 Aug 202345 days0000950170-23-042411
10-Q31 Mar 20239 May 202339 days0000950170-23-019714
10-K31 Dec 202214 Mar 202373 days0000950170-23-007869
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021885
10-Q30 Jun 20228 Aug 202239 days0000950170-22-015533
10-Q31 Mar 20229 May 202239 days0000950170-22-008500
10-K31 Dec 202110 Mar 202269 days0000950170-22-003369
10-Q30 Sep 20219 Nov 202140 days0000950170-21-003753
10-Q30 Jun 20219 Aug 202140 days0001564590-21-042734
10-Q31 Mar 202110 May 202140 days0001564590-21-026062

Source: SEC EDGAR company submissions for CIK 0001807120. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.